JFJohanna Feary

Johanna Feary

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Johanna Feary has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improving work participation in people with physical long-term health conditions. IMPPACT study

    by Johanna Feary

    Evidence suggests that good work can support health and provide benefits to society and the economy. This study examined how people with physical long-term health conditions (pLTCs) experience work whether they wish to increase their work participation what support they may need from clinical teams Participants included people taking medicines that help slow down their disease prevent long-term damage improve their health and daily life We focused on four health conditions: Cystic fibrosis (CF) which is a condition that causes thick, sticky mucus to build up in the lungs and digestive system, leading to breathing and digestion problems Inflammatory bowel disease (IBD) which is a condition where the immune system causes inflammation in the gut, leading to symptoms such as abdominal pain, diarrhoea, and fatigue Severe asthma (SA) which is a condition where inflammation and narrowing of the airways cause ongoing breathing difficulties Sickle cell disease (SCD) which is a condition in which red blood cells become sickle (or curved) shaped, causing anaemia, painful episodes, and sometimes serious problems due to reduced blood flow. For this study, increased work participation was defined as working additional hours, duties, or gaining employment. What we did We explored the potential for developing a support programme and methods of its delivery. The research comprised four phases: 1: A broad review of past research of existing interventions for people with these conditions. 2: Ten clinical services who prescribe specialist medicines were asked to provide clinic-level data. 3: Patients completed a survey about their employment (current/past), health, and views about work. 4: Participant interviews to explore their experiences in greater depth. What we found A total of 40,635 studies were identified in phase 1. Eight studies met the rules for including studies, describing four intervention types work adaptation counselling/coaching drug treatment a screening tool All studies reported positive findings e.g. improved wellbeing and reduced sickness absence. Study limitations prevented assessment of intervention effectiveness and none reported participants’ occupations or employment sectors. The review highlighted substantial evidence gaps relating to work-participation interventions for adults with these conditions and recommended further research. For phase 2, only three clinical services provided data. No meaningful conclusions could be drawn about the wider patient populations due to the extent of missing data and due to the services serving similar city populations. Participants were recruited from ten clinics across six NHS organisations in phase 3. Recruitment target was 400 participants (100 per condition). Four clinics achieved their target. Overall, 487 individuals were screened. Of these, 296 consented to the study and 267 participants completed the survey. Most participants were female and, with the exception of the SCD group, of White ethnicity. Ages ranged from 21-to-62 years. Overall, 54% had a university degree and approximately 70% were employed. Among those not in work, health was the common reason for unemployment. Confidence in returning-to-work was low and 43% of participants reported depression symptoms. In the final phase, 22 participants were interviewed. Analysis identified five themes reflecting experiences of managing a pLTC in relation to work: Unpredictable nature of living with a pLTC. Challenges associated with symptom management. Disruption to work participation due to symptoms and treatment demands. Difficulties navigating complex and poorly coordinated healthcare systems. Limited psychological support and challenges managing treatment side effects and their impact on work. Participants identified factors supporting work participation, including flexible working arrangements (home working and part-time work) alongside supportive managers and employers. What does this mean for future research and care? Most respondents had high education qualifications and were already in employment. Although difficulty working due to illness was reported across all conditions, mental health, stress and effective self-management emerged as important unmet needs. Among those in work, most wished to maintain or reduce their working hours. The study did not examine access to or benefit of occupational health support or workplace adjustments. The research reviewed the challenges experienced by people living with pLTCs while receiving specialist medicines. However, the findings did not capture participants' personal circumstances in sufficient depth to inform the development of a future funding application or a defined support programme. Several factors informed this conclusion: 1) Limited clarity regarding the content of a support programme, the most appropriate setting for delivery and the patient groups most likely to benefit, with little evidence supporting delivery through hospital or specialist care services. 2) Recruitment challenges encountered in this study, consistent with those reported in previous studies. 3) Recognition that work should be considered within the broader context of health, wellbeing and everyday life rather than as a standalone outcome. Next steps Further research exploring what works, for whom, and why is recommended. This would help address important unanswered questions arising from the present study. For example, future research could explore the contribution of both health-related and non-health-related factors associated with work participation, including demands of treatment, appointment schedules, job flexibility and employer support. It could also help determine where support programmes might be most appropriately delivered, taking into consideration emerging models such as neighbourhood health hubs announced by the UK Government in the NHS 10 Year Health Plan. Patient and Public Involvement Two members of the public with lived experience...

  • Longitudinal change in respiratory function in firefighters; results from the Grenfell Firefighter Study

    by Johanna Feary, Tamanna Kabir, Adrian Bevan, Susie Schofield

    Background The Grenfell Tower (GT) fire in 2017 exposed firefighters to unusually high smoke levels. Lung function changes attributed to 9/11 and wildfires are not generalisable to the UK urban setting. The Grenfell Firefighter Study (GFS) was set up to investigate the health risks of firefighting; specifically the association between occupational smoke exposure at the GT fire and lung function. Methods 685 firefighters from the London Fire Brigade (LFB) were recruited to the GFS. At a single study visit, spirometry was performed and a questionnaire completed. Historical occupational health spirometry records were obtained. Exposure was defined by GT fire attendance: fire phase (first 23h), recovery phase (day 2-13) or non-attendance. Piecewise linear mixed models were used to analyse slopes of absolute forced expiratory volume in one second (FEV1) pre and post GT fire using splines and adjusting for confounders. Results We had 2722 usable spirometry records for 684 firefighters (mean age 45 years, 95% male, 33% ever smokers). Differences in slopes pre-and post-fire in mls/year were -34.9 (95%CI -60.0, -41.9), -40.8 (-54.3, -27.2) and -34.9 (-44.7, -25.2) for non-attendees, recovery and fire phases respectively. (figure) The difference in slopes (pre-and post) for the fire phase vs non-attendees was -0.12mls/yr (-18.0, 17.7). Conclusion Initial analyses show a steeper decline in FEV1 post GT fire; but no meaningful differences between exposure groups suggesting observed decline was due to other factors. erj;68/suppl_70/PA6003/F1 F1 F1

  • Open Access

    Adjusting for the diagnostic accuracy of CXR in the dose-response relationship between cumulative silica exposure and silicosis in miners

    by Patrick Howlett, Ashwin Durairaj, Jeffrey Gan, Maia Lesosky, Johanna Feary

    Introduction: A recent meta-analysis confirmed that chest X-ray (CXR) has low sensitivity for diagnosing silicosis. We re-estimated previously published dose-response relationships between cumulative respirable crystalline silica (RCS) exposure and silicosis risk, under the assumptions that sensitivity was either fixed or relative to the population proportion of severe silicosis. Methods: We combined unpublished logistic regression models from Scottish coal miners with meta-analysis results to model how CXR sensitivity changed according to cumulative RCS exposure. We assumed specificity was 0.95. Among mining cohorts, we calculated the difference in the cumulative risk of silicosis between the unadjusted and fixed and relative scenarios. Finally, we re-estimated a published dose-response meta-analysis and associated absolute risk reductions (ARR). Results: The cumulative risk of silicosis was substantially higher in both the fixed and relative sensitivity scenarios compared with the unadjusted estimate in all mining cohorts. This was most pronounced in the relative scenario and when cumulative RCS exposures were below approximately 6 mg/m³-years. A reduction in cumulative RCS exposure from 4 to 2mg/m³-years corresponded to larger ARRs in the fixed and relative scenarios than the unadjusted scenario; 382 (95% CI 361 to 399) and 529 (95% CI 353 to 592) cases per 1000 miners compared with 313 (95% CI 288 to 333) cases per 1000 miners, respectively. Discussion: We relied on a single estimate of the proportion of severe disease to link sensitivity and cumulative RCS exposure. Nevertheless, adjusting for the reduced diagnostic accuracy of CXR for silicosis suggests the burden of silicosis is underestimated in published mining cohorts.

  • Silicosis in the Artificial Stone Countertop Industry: An Official American Thoracic Society Workshop Report

    by Sheiphali A Gandhi, Gabrielle Y Liu, Jane C Fazio, Olawale Amubieya, Hayley Barnes, Catherine Cavalin, Robert A Cohen, Elizabeth Fireman, Sandra R Garcia, Robert J Harrison, et al.

    Artificial stone–associated silicosis (AS silicosis) has emerged over the past decade as a severe, rapidly progressive, and preventable occupational lung disease affecting workers who manufacture, fabricate, and install artificial stone countertops. Characterized by short latency, accelerated progression, and high morbidity and mortality, AS silicosis disproportionately affects young workers employed in precarious conditions. In response to the growing global burden of disease, this American Thoracic Society workshop was convened in 2025 to review the current state of knowledge regarding AS silicosis, synthesize the current evidence, and identify priorities for research, clinical care, public health surveillance, and prevention. Workshop participants reviewed data spanning exposure science, epidemiology, clinical manifestations, health equity, and policy responses. Evidence demonstrates that artificial stone (AS) dust is highly toxic, containing high concentrations of respirable crystalline silica, resin-derived volatile compounds, and trace metals, resulting in exposures that routinely exceed occupational exposure limits. Despite widespread implementation of wet methods, ventilation, and respiratory protection, hazardous exposures persist across diverse settings globally, highlighting fundamental limitations of existing control strategies. Clinically, AS silicosis is associated with high rates of progressive massive fibrosis, autoimmune disease, infection, respiratory failure, and increasing need for lung transplantation. Treatment options remain limited, underscoring the importance of early detection and exposure cessation. The workshop identified critical gaps in medical screening and public health surveillance worldwide, with inconsistent regulatory frameworks, low compliance, underreporting, and delayed diagnoses. Case detection is often dependent on symptomatic presentation rather than proactive screening, exacerbating disease severity and inequities in care. International experiences illustrate both the consequences of regulatory inaction and the potential impact of decisive interventions, including Australia’s prohibition of crystalline silica–containing artificial stone. This report concludes that AS silicosis represents a failure of primary prevention and calls for coordinated global action. Key priorities include strengthening surveillance systems, ensuring equitable access to screening and care, developing effective therapeutics, advancing exposure science, and implementing higher-order preventive strategies, including the elimination or substitution of high-silica AS. Without urgent and sustained intervention, these products will continue to impose devastating and avoidable harm on workers worldwide.


  • Open Access

    Patterns of Mouse Allergen–Specific IgE and IgG4 in Contemporary Animal Research Environments

    by Jennifer Canizales, Susie Schofield, Mohamed H. Shamji, Paul Cullinan, Meinir Jones, Johanna Feary

    Summary: Mouse‐sensitised laboratory workers without asthma symptoms have higher mouse‐specific IgG4 than those with symptoms. Mouse‐specific IgG4 in workers' serum is associated with inhibiting IgE‐allergen complex binding to B cells.

  • Open Access

    The UK Silicosis Registry

    by Johanna Feary

  • Open Access

    Diagnostic accuracy of chest X-ray screening for silicosis: a systematic review, meta-analysis and modelling study

    by Patrick Howlett, Ashwin Durairaj, Maia Lesosky, Johanna Feary

    Chest X-ray (CXR) is widely used for silicosis diagnosis, despite concerns regarding sensitivity. We investigated the diagnostic accuracy of CXR for silicosis screening compared with CT, high-resolution CT (HRCT) and autopsy, and modelled the relationship between CXR sensitivity and disease severity. Medline, Embase, Scopus and Web of Science databases were searched on 2 July 2024 (PROSPERO registration: CRD42024513830). Meta-analyses were performed by reference standard and at increasing reference test severity cut-offs. The Quality Assessment of Diagnostic Accuracy Studies-2 tool assessed risk of bias. In scenarios of fixed and relative sensitivity, according to disease severity, we estimated missed silicosis cases and the number needed to screen (NNS) in hypothetical populations of low (5%), medium (15%) and high (30%) silicosis prevalence. Twenty studies included 2156 participants and 1105 silicosis cases. CXR had moderate sensitivity (0.76; 95% CI 0.63 to 0.86, I 2 =84%) and high specificity (0.89, 95% CI 0.77 to 0.95, I 2 =57%) compared with HRCT in 12 studies, and low sensitivity (0.50, 95% CI 0.45 to 0.55, I 2 =0%) and high specificity (0.91, 95% CI 0.87 to 0.93, I 2 =20%) compared with autopsy in two studies. CXR sensitivity increased with higher reference test severity cut-offs. Clinically relevant numbers of cases were missed in fixed and relative sensitivity scenarios; increased prevalence and less severe disease resulted in more missed cases and a lower NNS. Silicosis severity and reference test type both plausibly influence CXR sensitivity. Assuming either fixed or relative sensitivity results in missed silicosis cases. Judicious HRCT screening is likely to improve case detection.


  • Gene–occupational exposure interactions in small airways obstruction in the UK Biobank: a cross-sectional study

    by Valentina Quintero Santofimio, Diana van der Plaat, Elaine Fuertes, James Potts, Hans Kromhout, Johanna Feary, Andre F S Amaral

    Objectives: Small airways obstruction (SAO) has been associated with lifetime exposure to several agents in the workplace. Whether this association is modified by genetic variants is unknown. Methods: Using data from 147 317 adults (33 552 with SAO; 108 762 without SAO) participating in the UK Biobank, we conducted a genome-wide association analysis to identify genetic variants associated with SAO at baseline, defined as the forced expiratory volume in 3 s to 6 s ratio (FEV 3 /FEV 6 ) below the lower limit of normal. We assigned occupational exposures using the ALOHA+ job exposure matrix. Using cross-sectional data from 38 911 participants (8363 with SAO; 30 548 without SAO), who had complete job histories, we assessed whether the identified genetic variants interacted with occupational exposures on SAO using logistic regression models adjusted for confounders. Additionally, we investigated whether gene–occupational exposure signals were associated with gene expression in lung tissue. Results: We identified 36 genetic variants significantly associated with SAO. Eight of these significantly modified the association of SAO with pesticides, vapour, gases, dusts, fumes and metals, with participants homozygous for the reference allele being at increased risk of SAO when exposed to these agents. Only two of these genetic variants (rs9273529 and rs644045) appeared to affect gene expression in lung tissue. We found no significant interactions with solvents. Conclusions: Using a large population-based cohort, we identified genetic variants that interact and modify the association between SAO and several common workplace exposures. Further research is needed to confirm these effect modification findings and clarify potential biological mechanisms.


  • Open Access

    Adjusting for the reduced sensitivity of CXR in the dose-response relationship between cumulative silica exposure and silicosis in miners

    by Patrick Howlett, Ashwin Durairaj, Jeffery Gan, Maia Lesosky, Johanna Feary

    Introduction: A recent meta-analysis confirmed that Chest Xray (CXR) has low sensitivity for the diagnosis of silicosis however the impact of this is unclear. We therefore re- estimated a previously published dose-response relationship between cumulative respirable crystalline silica (RCS) exposure and silicosis risk, under the assumptions that sensitivity was either fixed or relative to the population proportion of severe silicosis. Methods: We combined unpublished logistic regression models from Scottish coal miners with meta-analysis results to model how CXR sensitivity changed according to cumulative RCS exposure. Among mining cohorts, we calculated the difference in the cumulative risk of silicosis between the unadjusted, and fixed and relative scenarios. Finally, we re-estimated the dose-response meta-analysis and related absolute risk reductions (ARR). Results: In all mining cohorts the cumulative risk of silicosis was substantially higher in both the fixed and relative sensitivity scenarios compared to the unadjusted estimate. This was most pronounced in the relative scenario and when cumulative RCS exposures were below approximately 6 mg/m 3 -years. A reduction from 4 to 2 mg/m 3 -years in cumulative RCS exposure corresponded to larger ARRs in the fixed and relative scenario than the unadjusted scenario; 409 (374, 434) and 557 (451, 620) cases per 1000 miners compared to 323 (298, 344) cases per 1000 miners, respectively. Discussion: We were reliant on a single estimate of the proportion of severe disease to link sensitivity and cumulative RCS exposure. Nevertheless, adjusting for the low sensitivity of CXR for silicosis results in meaningful increased risks of silicosis in previously published mining cohorts.


  • Open Access

    The diagnostic accuracy of chest Xray screening for silicosis: A systematic review, meta-analysis and modelling study

    by Patrick Howlett, Ashwin Durairaj, Maia Lesosky, Johanna Feary

    Objectives: Chest Xray (CXR) is widely used for silicosis diagnosis, despite concerns regarding sensitivity. We investigated the diagnostic accuracy of CXR for silicosis screening compared to computed tomography (CT), high-resolution CT (HRCT) and autopsy, and modelled the relationship between CXR sensitivity and disease severity. Methods: Medline, Embase, Scopus, and Web of Science databases were searched on 2 nd July 2024 (Prospero registration: CRD42024513830). Meta-analyses were performed by reference standard and at increasing reference test severity cut-offs. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool assessed risk of bias. In scenarios of fixed and relative sensitivity, according to disease severity, we estimated missed silicosis cases and the number needed to screen (NNS) in hypothetical populations of low (5%), medium (15%) and high (30%) silicosis prevalence. Results: Twenty studies included 2156 participants and 1105 silicosis cases. CXR had moderate sensitivity (0.76; 95% confidence interval (CI): 0.63-0.86, I 2 =84%) and high specificity (0.89, 95% CI: 0.77-0.95, I 2 =57%) compared to HRCT in 12 studies, and low sensitivity (0.50, 95% CI: 0.45-0.55, I 2 =0%) and high specificity (0.91, 95% CI: 0.87-0.93, I 2 =20%) compared to autopsy in two studies. CXR sensitivity increased with higher reference test severity cut-offs. Clinically relevant numbers of cases were missed in fixed and relative sensitivity scenarios; increased prevalence and less severe disease resulted in more missed cases and a lower NNS. Conclusions: Silicosis severity and reference test type both plausibly influence CXR sensitivity. Assuming either fixed or relative sensitivity results in missed silicosis cases. Judicious HRCT screening is likely to improve case detection. What is already known on this topic: It is widely understood that Chest Xray (CXR) underdiagnoses silicosis compared to more accurate methods, such as high resolution computed tomography (HRCT) and autopsy. What this study adds: Our systematic review and meta-analysis demonstrated that the sensitivity of CXR was lowest when compared to autopsy (50%), followed by HRCT (76%). This difference may be explained by the increased accuracy of autopsy as a reference test. Another potential explanation for differences between study results could be that – because severe silicosis is more easily diagnosed by CXR – studies with a higher proportion of severe disease recorded higher sensitivity results. Importantly, regardless of whether differences between studies are explained by different reference test modalities or the proportion of severe disease, when modelled among a population of silica-exposed workers, many silicosis cases are missed. How this study might affect research, practice or policy: This study suggests the careful implementation of HRCT screening for silicosis would improve case detection.